Loading...
XIST
HEKTS
Market cap588mUSD
Nov 12, Last price  
3.28TRY
Name

Hektas Ticaret TAS

Chart & Performance

D1W1MN
XIST:HEKTS chart
P/E
P/S
4.49
EPS
Div Yield, %
Shrs. gr., 5y
12.30%
Rev. gr., 5y
43.42%
Revenues
6.15b
+26.39%
74,935,95384,634,532102,062,877117,445,535113,002,194138,747,248160,970,342176,777,933252,213,516497,071,893732,677,5041,013,719,1292,020,718,3365,237,435,1346,038,995,4094,867,088,0006,151,490,000
Net income
-4.05b
L+48.39%
5,670,35314,368,41712,881,92419,454,26918,033,76122,221,72624,249,57729,341,90849,239,871106,192,653145,571,250178,656,607319,390,940802,289,709-878,239,047-2,726,726,000-4,046,104,000
CFO
1.93b
-51.38%
22,398,447-8,339,4079,230,13923,134,202-1,152,07836,501,87426,666,630-6,411,335-185,870,45774,651,445-146,779,415-463,582,595-2,495,274,1291,477,969,5553,974,957,0001,932,502,053
Dividend
Dec 02, 20190.0262 TRY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Hektas Ticaret T.A.S., founded in 1956 and headquartered in Gebze, Turkey, is a leading Turkish company that manufactures, imports, and distributes a wide spectrum of agricultural and veterinary products. For the agricultural sector, their offerings include an extensive range of crop protection solutions such as fungicides, herbicides, insecticides, acaricides, biological insecticides, fumigants, nematicides, soil fumigants, and plant growth regulators. They also provide specialized winter care treatments, summer oils, and spreading agents. Furthermore, Hektas supplies various fertilizers, including foliar applications, organo-mineral compounds, and drip irrigation products, alongside other farming essentials and even tomato seeds. In the animal health domain, the company offers a diverse portfolio of veterinary pharmaceuticals, encompassing antibacterials, vitamin and mineral supplements, feed additives, anti-inflammatory drugs, and anti-parasitics. Their product line additionally features poultry health remedies, pet care items, and pet food.
IPO date
Jan 13, 1986
Employees
Domiciled in
TR
Incorporated in
TR

Valuation

Title
TRY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT